You are here:   Videos
Register   |  Login

Get Adobe Flash player Install latest flash player if this video gallery doesn't work.
Update on JAK Inhibitor — COMFORT II Trial interview with Claire Harrison, MD, at ASH 2011
At the American Society of Hematology (ASH) 2011, Claire Harrison, MD, discusses the updated analysis of the COMFORT II Study, which includes the significance of a 35% reduction in spleen volume in all subgroups. Also discussed are health-related quality of life and symptoms in myelofibrosis patients treated with ruxolitinib versus best available therapy, as well as other pertinent clinical information.

Accompanying this interview are two downloadable slide decks of the abstracts.
Recent Video
| 
Most Viewed
Tumor Type : Search :